RunTang Zhou, YanHong Wei, Yingguan Xiong, BingBing Su, JunHao Xie, Linlin Hu, XiaoCan Lei
{"title":"人工智能在原发性卵巢功能不全治疗中的机遇与挑战。","authors":"RunTang Zhou, YanHong Wei, Yingguan Xiong, BingBing Su, JunHao Xie, Linlin Hu, XiaoCan Lei","doi":"10.1007/s10815-025-03660-w","DOIUrl":null,"url":null,"abstract":"<p><p>Primary ovarian insufficiency (POI) is also known as premature ovarian failure (POF), defined as loss of normal, predictable ovarian activity before the age of 40 years. In addition, POI patients suffer from long-term complications such as osteoporosis, cardiovascular disease, and depression. The impact on women caused by POI and its complications make it become a major health challenge worldwide. The recent advances in digital health technology (DHT), especially artificial intelligence (AI), provide an important opportunity to improve the efficiency of the management of POI. Clinical work has improved the efficiency of healthcare with the assistance of AI, enabling clinicians to improve clinical treatment efficiency, and mitigate the differences in healthcare level caused by suboptimal resource allocation. This article reviews the application progress of AI in the treatment of POI in recent years, and discusses the opportunities and challenges of AI in clinical application. In addition, we explored the integration of existing digital health technology resources to discuss an AI-assisted eco-smart healthcare system for the treatment of POI.</p>","PeriodicalId":15246,"journal":{"name":"Journal of Assisted Reproduction and Genetics","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Artificial intelligence in primary ovarian insufficiency management: opportunities and challenges.\",\"authors\":\"RunTang Zhou, YanHong Wei, Yingguan Xiong, BingBing Su, JunHao Xie, Linlin Hu, XiaoCan Lei\",\"doi\":\"10.1007/s10815-025-03660-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Primary ovarian insufficiency (POI) is also known as premature ovarian failure (POF), defined as loss of normal, predictable ovarian activity before the age of 40 years. In addition, POI patients suffer from long-term complications such as osteoporosis, cardiovascular disease, and depression. The impact on women caused by POI and its complications make it become a major health challenge worldwide. The recent advances in digital health technology (DHT), especially artificial intelligence (AI), provide an important opportunity to improve the efficiency of the management of POI. Clinical work has improved the efficiency of healthcare with the assistance of AI, enabling clinicians to improve clinical treatment efficiency, and mitigate the differences in healthcare level caused by suboptimal resource allocation. This article reviews the application progress of AI in the treatment of POI in recent years, and discusses the opportunities and challenges of AI in clinical application. In addition, we explored the integration of existing digital health technology resources to discuss an AI-assisted eco-smart healthcare system for the treatment of POI.</p>\",\"PeriodicalId\":15246,\"journal\":{\"name\":\"Journal of Assisted Reproduction and Genetics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Assisted Reproduction and Genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10815-025-03660-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Assisted Reproduction and Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10815-025-03660-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Artificial intelligence in primary ovarian insufficiency management: opportunities and challenges.
Primary ovarian insufficiency (POI) is also known as premature ovarian failure (POF), defined as loss of normal, predictable ovarian activity before the age of 40 years. In addition, POI patients suffer from long-term complications such as osteoporosis, cardiovascular disease, and depression. The impact on women caused by POI and its complications make it become a major health challenge worldwide. The recent advances in digital health technology (DHT), especially artificial intelligence (AI), provide an important opportunity to improve the efficiency of the management of POI. Clinical work has improved the efficiency of healthcare with the assistance of AI, enabling clinicians to improve clinical treatment efficiency, and mitigate the differences in healthcare level caused by suboptimal resource allocation. This article reviews the application progress of AI in the treatment of POI in recent years, and discusses the opportunities and challenges of AI in clinical application. In addition, we explored the integration of existing digital health technology resources to discuss an AI-assisted eco-smart healthcare system for the treatment of POI.
期刊介绍:
The Journal of Assisted Reproduction and Genetics publishes cellular, molecular, genetic, and epigenetic discoveries advancing our understanding of the biology and underlying mechanisms from gametogenesis to offspring health. Special emphasis is placed on the practice and evolution of assisted reproduction technologies (ARTs) with reference to the diagnosis and management of diseases affecting fertility. Our goal is to educate our readership in the translation of basic and clinical discoveries made from human or relevant animal models to the safe and efficacious practice of human ARTs. The scientific rigor and ethical standards embraced by the JARG editorial team ensures a broad international base of expertise guiding the marriage of contemporary clinical research paradigms with basic science discovery. JARG publishes original papers, minireviews, case reports, and opinion pieces often combined into special topic issues that will educate clinicians and scientists with interests in the mechanisms of human development that bear on the treatment of infertility and emerging innovations in human ARTs. The guiding principles of male and female reproductive health impacting pre- and post-conceptional viability and developmental potential are emphasized within the purview of human reproductive health in current and future generations of our species.
The journal is published in cooperation with the American Society for Reproductive Medicine, an organization of more than 8,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology.